Keith Jensen

Dr. Jensen brings 17 years of pharma experience specializing in continuous manufacturing of pharmaceuticals and early- to late-stage solid dosage formulation development. He currently serves on the USP Quality Standards for Pharmaceutical Continuous Manufacturing Expert Panel previously served as the Associate Director of Novartis-MIT Center for Continuous Manufacturing. Prior to that, he served as Director of Formulation at LTS Lohmann Therapy Systems, a CDMO, where he led the formulation development of three FDA-approved products.